Role of morphine, miR-212/132 and mu opioid receptor in the regulation of Bdnf in zebrafish embryos

被引:29
作者
Jimenez-Gonzalez, Ada [2 ,3 ]
Garcia-Concejo, Adrian [2 ,3 ]
Lopez-Benito, Saray [2 ,3 ]
Gonzalez-Nunez, Veronica [1 ,2 ,3 ]
Carlos Arevalo, Juan [2 ,3 ,4 ]
Rodriguez, Raquel E. [1 ,2 ,3 ]
机构
[1] Univ Salamanca, Dept Biochem & Mol Biol, E-37008 Salamanca, Spain
[2] Univ Salamanca, Inst Neurosci Castilla & Leon INCyL, E-37008 Salamanca, Spain
[3] Inst Biomed Res Salamanca IBSAL, Salamanca, Spain
[4] Dept Cell Biol & Pathol, Salamanca, Spain
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2016年 / 1860卷 / 06期
关键词
miR-132; miR-212; Morphine; Bdnf; Danio rerio; MOR-1; GENE-EXPRESSION; NEUROTROPHIC FACTOR; NERVOUS-SYSTEM; COCAINE INTAKE; DANIO-RERIO; MICRORNAS; NEURONS; BRAIN; PAIN; NEUROPROTECTION;
D O I
10.1016/j.bbagen.2016.03.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Morphine is one of the first-line therapies for the treatment of pain despite its secondary effects. It modifies the expression of epigenetic factors like miRNAs. In the present study, we analyzed miR-212 and miR-132 and their implication in morphine effects in the zebrafish Central Nervous System (CNS) through the regulation of Bdnf expression. Methods: We used control and knock-down zebrafish embryos to assess the effects of morphine in miRNAs 212/132 and mitotic or apoptotic cells by qPCR, immunohistochemistry and TUNEL assay, respectively. Bdnf and TrkB were studied by western blot and through a primary neuron culture. A luciferase assay was performed to confirm the binding of miRNAs 212/132 to mecp2. Results: Morphine exposure decreases miR-212 but upregulates miR-132, as wells as Bdnf and TrkB, and changes the localization of proliferative cells. However, Bdnf expression was downregulated when miRNAs 212/132 and oprml were knocked-down. Furthermore, we proved that these miRNAs inhibit mecp2 expression by binding to its mRNA sequence. The described effects were corroborated in a primary neuron culture from zebrafish embryos. Conclusions: We propose a mechanism in which morphine alters the levels of miRNAs 212/132 increasing Bdnf expression through mecp2 inhibition. oprml is also directly involved in this regulation. The present work confirms a relationship between the opioid system and neurotrophins and shows a key role of miR-212 and miR-132 on morphine effects through the regulation of Bdnf pathway. General significance.: miRNAs 212/132 are novel regulators of morphine effects on CNS. Oprm1 controls the normal expression of Bdnf. (C) 2016 Published by Elsevier B.V.
引用
收藏
页码:1308 / 1316
页数:9
相关论文
共 61 条
[1]   EFFECTS OF ENVIRONMENTAL ENRICHMENT ON BEHAVIORAL DEFICITS AND ALTERATIONS IN HIPPOCAMPAL BDNF INDUCED BY PRENATAL EXPOSURE TO MORPHINE IN JUVENILE RATS [J].
Ahmadalipour, A. ;
Sadeghzadeh, J. ;
Vafaei, A. A. ;
Bandegi, A. R. ;
Mohammadkhani, R. ;
Rashidy-Pour, A. .
NEUROSCIENCE, 2015, 305 :372-383
[2]   BASIC LOCAL ALIGNMENT SEARCH TOOL [J].
ALTSCHUL, SF ;
GISH, W ;
MILLER, W ;
MYERS, EW ;
LIPMAN, DJ .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) :403-410
[3]   New kappa opioid receptor from zebrafish Danio rerio [J].
Alvar Alvarez, Franscisco ;
Rodriguez-Martin, Ivan ;
Gonzalez-Nunez, Veronica ;
Fernandez de Velasco, Ezequiel Marron ;
Gonzalez Sarmiento, Rogelio ;
Rodriguez, Raquel E. .
NEUROSCIENCE LETTERS, 2006, 405 (1-2) :94-99
[4]   Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers [J].
Balcells, Ingrid ;
Cirera, Susanna ;
Busk, Peter K. .
BMC BIOTECHNOLOGY, 2011, 11
[5]  
Bali Purva, 2013, Frontiers in Genetics, V4, P43, DOI 10.3389/fgene.2013.00043
[6]   THE TRK FAMILY OF NEUROTROPHIN RECEPTORS [J].
BARBACID, M .
JOURNAL OF NEUROBIOLOGY, 1994, 25 (11) :1386-1403
[7]   ZFOR2, a new opioid receptor-like gene from the teleost zebrafish (Danio rerio) [J].
Barrallo, A ;
González-Sarmiento, R ;
Alvar, F ;
Rodríguez, RE .
MOLECULAR BRAIN RESEARCH, 2000, 84 (1-2) :1-6
[8]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[9]  
Berillo O.A., 2013, Afr. J. Biotechnol, V12, P1016
[10]  
Berrios I, 2008, P R HEALTH SCI J, V27, P119